AngioDynamics (UG2) Q4 2026 Earnings Report
DE:UG2 Q4 2026 EPS Results
- Actual EPS
- -EUR 0.06
- Consensus EPS
- -EUR 0.08
- Beat/Miss
- Beat by +EUR 0.02
- One Year Ago EPS
- -EUR 0.03
DE:UG2 Q4 2026 Revenue Results
- Actual Revenue
- EUR 77.11M
- Expected Revenue
- EUR 71.44M
- Beat/Miss
- Beat by +EUR 5.67M
- YoY Revenue Growth
- +8.05%
Earnings Announcement Details
- Quarter
- Q4 2026
- Date
- 07/14/2026
- Time
- Before Open
- Conference Call
- Tuesday, July 14, 2026
DE:UG2 Upcoming Earnings
AngioDynamics's next earnings date is estimated for January 7, 2027, based on past reporting schedules.
Q4 2026 Earnings Call Audio
DE:UG2 Q4 2026 Earnings Call
0:00 / 0:00
Q4 2026 Earnings Slide Deck
Q4 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:UG2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 07, 2027 | 2027 (Q2) | -0.06- | 0 | ― | ― |
| Oct 08, 2026 | 2027 (Q1) | -0.10-0.04 | -0.09 | 60.00% (+0.05) | |
| Jul 14, 2026 | 2026 (Q4) | -0.08-0.06 | -0.03 | -133.33% (-0.04) | |
| Apr 02, 2026 | 2026 (Q3) | -0.100.02 | -0.07 | 125.00% (+0.09) | |
| Jan 06, 2026 | 2026 (Q2) | -0.090.00 | -0.04 | 100.00% (+0.04) | |
| Oct 02, 2025 | 2026 (Q1) | -0.11-0.09 | -0.1 | 9.09% (+0.01) | |
| Jul 15, 2025 | 2025 (Q4) | -0.11-0.03 | -0.05 | 50.00% (+0.03) | |
| Apr 02, 2025 | 2025 (Q3) | -0.12-0.07 | -0.14 | 50.00% (+0.07) | |
| Jan 08, 2025 | 2025 (Q2) | -0.10-0.04 | -0.04 | 20.00% (+0.01) | |
| Oct 03, 2024 | 2025 (Q1) | -0.13-0.10 | -0.11 | 8.33% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
